220 related articles for article (PubMed ID: 33505426)
1. YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.
Shen X; Zhao K; Xu L; Cheng G; Zhu J; Gan L; Wu Y; Zhuang Z
Front Genet; 2020; 11():592042. PubMed ID: 33505426
[TBL] [Abstract][Full Text] [Related]
2. YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance.
Yang J; Chen Y; He Y; Da M
Drug Dev Res; 2024 Apr; 85(2):e22179. PubMed ID: 38616512
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.
Yang H; Hu Y; Weng M; Liu X; Wan P; Hu Y; Ma M; Zhang Y; Xia H; Lv K
J Adv Res; 2022 Mar; 37():91-106. PubMed ID: 35499052
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 exerts tumor-suppressor roles in gastric cancer via up-regulating PPP2CA independently of m
Zhou Y; Fan K; Dou N; Li L; Wang J; Chen J; Li Y; Gao Y
Biol Proced Online; 2023 Mar; 25(1):6. PubMed ID: 36870954
[TBL] [Abstract][Full Text] [Related]
5. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
6. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
[TBL] [Abstract][Full Text] [Related]
7. YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway.
Zhao T; Wang M; Zhao X; Weng S; Qian K; Shi K; Gu Y; Ying W; Qian X; Zhang Y
Front Oncol; 2022; 12():763341. PubMed ID: 35186724
[TBL] [Abstract][Full Text] [Related]
8. PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.
Zhang Y; Zhou X; Cheng X; Hong X; Jiang X; Jing G; Chen K; Li Y
Neoplasma; 2022 Dec; 69(6):1338-1348. PubMed ID: 36305690
[TBL] [Abstract][Full Text] [Related]
9. Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism.
Chen X; Lu T; Ding M; Cai Y; Yu Z; Zhou X; Wang X
J Adv Res; 2023 Oct; ():. PubMed ID: 37865189
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
Mu Z; Dong D; Sun M; Li L; Wei N; Hu B
Front Oncol; 2020; 10():1566. PubMed ID: 33102202
[TBL] [Abstract][Full Text] [Related]
11. YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.
Chen J; Sun Y; Xu X; Wang D; He J; Zhou H; Lu Y; Zeng J; Du F; Gong A; Xu M
Cell Cycle; 2017; 16(23):2259-2271. PubMed ID: 29135329
[TBL] [Abstract][Full Text] [Related]
12. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
13. Systematic Analyses of the Role of the Reader Protein of
Shao XY; Dong J; Zhang H; Wu YS; Zheng L
Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
15. [Knockdown of YTH N
Zhang J; Pi J; Liu Y; Yu J; Feng T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1628-1634. PubMed ID: 29382422
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 Suppresses Notch Signaling through Post-transcriptional Regulation on Notch1.
Lee B; Lee S; Shim J
Int J Biol Sci; 2021; 17(14):3776-3785. PubMed ID: 34671198
[TBL] [Abstract][Full Text] [Related]
17. The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis.
Liu H; Zhang Z; Han Y; Fan A; Liu H; Zhang X; Liu Y; Zhang R; Liu W; Lu Y; Fan D; Zhao X; Nie Y
Front Oncol; 2021; 11():634579. PubMed ID: 33869020
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition.
Li Q; Wu J; Wei P; Xu Y; Zhuo C; Wang Y; Li D; Cai S
Am J Cancer Res; 2015; 5(6):2022-34. PubMed ID: 26269761
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
20. m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.
Yu R; Li Q; Feng Z; Cai L; Xu Q
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
